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least 52% Dominican American,  receiving  the  influenza vac-
cine at 29.53 ± 0.34 weeks gestation (Table 1). The frequency of 






























































Age at enrollment (yr, mean ± SEM) 25.41 ± 0.42





Anti-Fluzone and anti-MP OD ratios from cord blood following vaccination of the mothers. Positive and negative mean levels were each com-
pared with the mean anti-JE antibody for both Fluzone (A) and MP (B). Among cord blood samples with positive anti-IgM antibodies, levels were 
significantly greater than those measured in response to JE. *P < 0.01 versus JE.
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was  also  examined.  As  shown  in 























Identification of maternal and cord blood HA306–318–specific CD4+ T cells by 






























Results of Fluzone inhibition assay following vaccination of the mothers. 
Figure 3
Comparison of ODs. (A) Comparison between maternal and cord blood anti-Fluzone IgM. r = 0.26; 
P = 0.027. (B) Comparison between maternal and cord blood anti-MP IgM. r = 0.19; P = 0.1. (C) 
Comparison between maternal and cord blood anti-Fluzone IgG. r = 0.94; P < 0.0001. (D) Comparison 
between maternal and cord blood anti-MP IgG. r = 0.95; P < 0.0001.
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ity that tetramer positivity of cord blood specimens during flow 
cytometry represents contamination by maternal cells.
Identification of maternal and cord blood MP-specific CD8+ T cells by direct 











































Influenza antigen–specific CBMC proliferation was infrequent and 
























Discordance in anti-Fluzone and anti-MP IgM immune responses 
between maternal and cord blood
	 	 Maternal	blood
	 	 +	IgM	 –	IgM
	 Fluzone
 + IgM 10 17A
 – IgM 30 12
Cord	blood
	 MP
 + IgM 9 19A
 – IgM 10 41
ACord blood developed IgM even in the absence of mother’s IgM.
Figure 4
Representative tetramer 
staining of DRB1*0101+ cord 
blood stained with the DR1/HA 
tetramer (A), the same 
DRB1*0101+ cord blood 
stained with the DR4/HA 
negative control tetramer 
(B), and a sample from a 
DRB1*0101– adult volunteer 
stained with the DR1/HA 
tetramer (C). Panels show 
percentage of tetramer-stain-
ing–positive cells from a rep-
resentative subject.
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Representative comparison of tetramer staining in DRB1*0401+ and DRB1*0401– cord blood. (A and B) DR4 HLA typing by flow cytometry. (C) 
DRB1*0401+-HA T cell clone (HA136). (D) DRB1*0401+ inherited from father; staining performed with DR4/HA tetramer. (E) DRB1*0401+ inherited 
from father; staining performed with DR4/GAD tetramer. (F) DRB1*0401– newborn; staining performed with DR4/HA tetramer. (G) DRB1*0401– 
newborn; staining performed with DR4/GAD tetramer. Panels show percentage of tetramer-staining–positive cells from a representative subject.
research article































































staining of samples from an 
HLA A*0201+ adult volunteer 
following influenza vaccina-
tion; an HLA A*0201+ moth-
er after vaccination against 
influenza; and cord blood 
from her HLA A*0201– new-
born. Bottom row represents 
staining using a negative 
control tetramer (A2.1/Neg). 
The cord blood specimen 
was classified as negative. 
Panels show percentage of 
tetramer-staining–positive 
cells from a representative 
subject.
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Maternal and neonatal influenza-specific CD4+ T cells are CD45RO positive. Representative maternal PBMCs and CBMCs were stained with 
DR4/HA tetramers and anti-CD45RO antibody versus isotype control (data for the latter not shown). CD4+/DR4/HA+ T cell population was gated 
to quantify the CD45RO+ T cells. Background staining of postpartum maternal HLA DRB1*0401– PBMCs was 0.008%. Bottom panel indicates 
that maternal PBMCs and newborn CBMCs that stained with DR4/HA tetramer also expressed CD45RO (50% and 66.7% DR4/HA+ cells, 
respectively). Panels show percentage of tetramer-staining–positive cells from a representative subject.
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Comparison of cord blood tetramer staining with anti-influenza IgM production and T cell proliferation
	 Tetramer	result	 Anti-Fluzone	IgM	 Anti-MP	IgM	 Fluzone	proliferation
DRB1*0101+or DRB1*0401+ Positive (n = 9) 33.3% (2/6) 66.7% (4/6) 0% (0/4)
 Negative (n = 17) 37.5% (6/16) 25.0% (4/16) 22.2% (2/9)
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